Active Ingredient: RITONAVIR
Proprietary Name: RITONAVIR
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A205024
Product Number: 001
Approval Date: Feb 16, 2024
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
